Advertisement

Topics

Ascletis, Medivir sign development deal for its hepatitis C drug in China

04:42 EDT 21 Aug 2017 | SmartBrief

A development deal was closed by Ascletis to license the manufacture of Medivir's hepatitis C virus drug candidate MIV-802 in -More

Original Article: Ascletis, Medivir sign development deal for its hepatitis C drug in China

NEXT ARTICLE

More From BioPortfolio on "Ascletis, Medivir sign development deal for its hepatitis C drug in China"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...